On November 5, Boehringer Ingelheim and the Taizhou Pharmaceutical High-tech Zone Pharmaceutical Industrial Park signed a memorandum of cooperation at the 9th China International Import Expo, announcing further deepening strategic cooperation between the two sides in the field of animal health care. According to the memorandum of understanding, Boehringer Ingelheim plans to invest more than 100 million yuan to build an inactivated vaccine production line at the Taizhou Animal Health Business Base.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.